Role of mepartricin in patients with benign prostatic hypertrophy. Study of 24 patients
Fiorilla, C.; Mosele, G.
Minerva Urologica e Nefrologica 39(4): 369-372
1987
ISSN/ISBN: 0393-2249 PMID: 2453930 Document Number: 302279
Document emailed within 1 workday
Related Documents
Pisani, E. 1995: Multicenter clinical study of the effects of once daily administration of mepartricin 150.000 U. in benign prostatic hypertrophy Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 67(4): 223-230Giurioli, A.; Rosi, P.; Parziani, S.; Cesaroni, M.; Ghamari, M.R. 1988: Treatment of benign prostatic hypertrophy using mepartricin at high dosage Minerva Urologica e Nefrologica 40(2 Suppl): 38-39
Prezioso, D.; Mirone, V.; Fabrizio, F.; Lotti, T. 1996: Double-blind evaluation of mepartricin 150.000 U (40 mg) compared with placebo in benign prostatic hypertrophy Minerva Urologica e Nefrologica 48(4): 207-211
Fujita, K.; Sayama, T.; Abe, S.; Murayama, T.; Sugimoto, M.; Hara, T. 1985: A pharmacokinetic study of antibiotics in patients with benign prostatic hypertrophy Japanese Journal of Antibiotics 38(8): 2145-2148
Glémain, P.; Lenormand, L.; Buzelin, J.M.; Bertrand, D. 1992: Multifactorial urodynamic study of 115 patients with dysuria and benign prostatic hypertrophy Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 2(3): 363-371
Casella, G.; Barbaro, A. 1978: The role of mepartricin in the medical treatment of benign prostatic adenoma Archivio Per le Scienze Mediche 135(1): 95-98
Flamm, J.; Kiesswetter, H.; Englisch, M. 1979: An urodynamic study of patients with benign prostatic hypertrophy treated conservatively with phytotherapy or testosterone Wiener Klinische Wochenschrift 91(18): 622-627
Castro, J.E.; Griffiths, H.L. 1972: The assessment of patients with benign prostatic hypertrophy Journal of the Royal College of Surgeons of Edinburgh 17(3): 190-194
Shiraiwa, K.; Yamaguchi, C.; Kudo, T.; Ehara, T.; Miyazawa, K.; Sasagawa, M.; Tsugawa, R. 1986: Clinical studies on medical disorders of patients with benign prostatic hypertrophy over 65 years of age Hinyokika Kiyo. Acta Urologica Japonica 32(11): 1605-1609
Virgili, G.; Mearini, E.; Sbarberi, L.; Camilli, P.; Costantini, E. 1986: Therapeutic efficacy of mepartricin in the medical treatment of prostatic hypertrophy Minerva Medica 77(20): 861-866
Wu, J.P.; Gu, F.L.; Lu, E.X. 1983: Effects of phenoxybenzamine and prostigmine relative voiding resistance in patients with benign prostatic hypertrophy Chinese Medical Journal 96(1): 1-5
Uchida, J.; Kawamura, H.; Fujita, I.; Oguchi, N.; Matsuda, T.; Ashida, M.; Kikkawa, A.; Doi, T.; Amazutsumi, K.; Ohara, T. 1995: Clinical efficacy of the Porges Urospiral, a reversible intraprostatic spiral stent, in patients with benign prostatic hypertrophy Hinyokika Kiyo. Acta Urologica Japonica 41(4): 323-328
Suzuki, K.; Ichinose, Y.; Hashimoto, K.; Matsumoto, K.; Suzuki, T.; Imai, K.; Yamanaka, H. 1990: Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography Hinyokika Kiyo. Acta Urologica Japonica 36(5): 557-560
Nielsen, M.L.; Christensen, P.; Antoni, E. 1971: Total and tartrate-inhibited acid phosphatases in serum. Significance of rectal examination in normal individuals and patients with benign prostatic hypertrophy Ugeskrift for Laeger 133(46): 2279-2284
Fukuoka, H.; Ishibashi, Y.; Shiba, T.; Tuchiya, F.; Sakanishi, S. 1993: Clinical study of allylestrenol (Perselin) on patients with prostatic hypertrophy Hinyokika Kiyo. Acta Urologica Japonica 39(7): 679-683
Kazama, T.; Mizuno, I.; Takamine, T.; Umeda, K.; Terada, T.; Ishikawa, S.; Fuse, H.; Katayama, T. 1990: Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography Hinyokika Kiyo. Acta Urologica Japonica 36(12): 1423-1427
Park, Y.C.; Nishioka, T.; Arai, Y.; Tomoyoshi, T.; Kurita, T.; Hayashida, H.; Nagai, N.; Inoue, H.; Kataoka, K.; Kitagawa, Y. 1992: A multicenter, fixed-flexible dose study of terazosin hydrochloride in the treatment of symptomatic benign prostatic hypertrophy Hinyokika Kiyo. Acta Urologica Japonica 38(7): 857-868
Krieg, M.; Bartsch, W.; Herzer, S.; Becker, H.; Voigt, K.D. 1977: Quantification of androgen binding, androgen tissue levels, and sex hormone-binding globulin in prostate, muscle and plasma of patients with benign prostatic hypertrophy Acta Endocrinologica 86(1): 200-215
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216
Abdul-Muhsin, H.M.; Jakob, N.J.; McLemore, R.M.; McAdams, S.B.; Humphreys, M.R. 2016: Infectious complications associated with the use of temporary prostatic urethral stents in patients with benign prostatic hyperplasia Canadian Journal of Urology 23(5): 8465-8470